No heartburn? no problem? simple swallow test spots hidden esophagus risk

NCT ID NCT04880044

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new, office-based test called EsoCheck/EsoGuard to detect Barrett's esophagus in 132 people who do not have chronic heartburn but have other risk factors like being over 50, white, male, or having central obesity. Participants swallowed a capsule on a string to collect a sample from the esophagus, which was then tested for DNA markers. Those with a positive result underwent a standard endoscopy to confirm. The goal was to see how well this simpler test could identify Barrett's esophagus without needing a full endoscopic procedure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
EsoCheck/EsoGuard (EC/EG) diagnostic test
What this could lead to
If successful, this could offer a simple, non-endoscopic way to screen for Barrett's esophagus in people without heartburn, potentially catching the condition earlier.
What could go wrong
This is a small, completed study focused on diagnostic accuracy, not a treatment trial. The test may not be widely adopted or may miss some cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BARRETT'S ESOPHAGUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center

    Cleveland, Ohio, 44106-5065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.